1991
DOI: 10.1097/00007890-199102000-00027
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Patient Survival in a Pediatric Renal Transplantation Program

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
1

Year Published

1991
1991
2015
2015

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(4 citation statements)
references
References 0 publications
0
3
0
1
Order By: Relevance
“…Most available data pertain only to pediatric kidney recipients, because once recipients reach adulthood, they are no longer followed by the pediatric registry. A single-center analysis showed that, of children dying with graft function, cardiac events accounted for four (11%) of 36 deaths (83); in another series, deaths occurring 10 or more years post-transplant were all due to cardiovascular causes (84). Risk factors associated with increased CVD in adult kidney recipients (85) have also been reported in pediatric kidney recipients.…”
Section: Pediatric Recipientsmentioning
confidence: 99%
“…Most available data pertain only to pediatric kidney recipients, because once recipients reach adulthood, they are no longer followed by the pediatric registry. A single-center analysis showed that, of children dying with graft function, cardiac events accounted for four (11%) of 36 deaths (83); in another series, deaths occurring 10 or more years post-transplant were all due to cardiovascular causes (84). Risk factors associated with increased CVD in adult kidney recipients (85) have also been reported in pediatric kidney recipients.…”
Section: Pediatric Recipientsmentioning
confidence: 99%
“…Because patient and graft survival rates have improved for pediatric kidney Tx recipients, attention should now be given to CVD (and to CVD risk factors, such as hyperlipidemia), which may have an impact on outcome late post Tx [4,5]. Two small, single-center studies reported increased CVD mortality in long-term pediatric kidney recipients [6,7]. We used our University of Minnesota Tx database to determine the prevalence of hyperlipidemia in pediatric kidney recipients on cyclosporine (CsA) immunosuppression and to examine pre-and post-Tx factors associated with the development of hyperlipidemia.…”
Section: Introductionmentioning
confidence: 99%
“…/2015/ ТОМ 12/ № 5 АКТУАЛЬНОСТЬ Успешная трансплантация почки от живого родствен-ного донора (ЖРД) [1][2][3][4][5][6][7][8][9] является самым эффективным методом лечения детей с терминальной стадией хрони-ческой почечной недостаточности (ХПН): улучшаются рост и развитие детей, о чем свидетельствуют отдаленные результаты наблюдений многочисленных специализиро-ванных медицинских центров [3][4][5][6][7]. Ранее проведенные исследования были сосредоточены на изучении и анализе предпосылок, увеличивающих вероятность или реальность наступления неблагоприятных событий при пересадке органа [3][4][5]9].…”
Section: педиатрическая фармакологияunclassified